Acute leukaemia, Acute myeloid leukaemia (AML), Blood cancers, High grade lymphoma, Leukaemia, Lymphoma, Myelodysplastic syndrome (MDS), Myeloma, Non-Hodgkin lymphoma (NHL)
Open
Phase 1/2
This trial is for people with blood cancer that has come back or is getting worse despite treatment.
Currently it is open to people with one of the following types of blood cancer:
Recruitment start: 9 September 2019
Recruitment end: 31 December 2026
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Tim Somervaille
CellCentric Ltd
Last reviewed: 21 May 2026
CRUK internal database number: 17062